Clinical trial
An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT01711697
Study timeline
Study start (actual)2012-09-04Date precision: day
Registry last updated2021-06-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Stage IIA Non-small Cell Lung Cancerunresolved
Stage IIB Non-small Cell Lung Cancerunresolved
Stage IIIA Non-small Cell Lung Cancerunresolved
Stage IIIB Non-small Cell Lung Cancerunresolved
Interventions
stereotactic body radiation therapyRADIATION
carboplatinDRUG · verified · RxNorm: carboplatin
paclitaxelDRUG · verified · RxNorm: paclitaxel
radiation therapyRADIATION
Sponsors & collaborators
Emory Universitylead sponsor
Washington University Siteman Cancer Centercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01711697 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.